...
首页> 外文期刊>Marine Drugs >Identification of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Enzymatic Hydrolysates of Razor Clam Sinonovacula constricta
【24h】

Identification of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Enzymatic Hydrolysates of Razor Clam Sinonovacula constricta

机译:剃刀C中华新nova的酶解产物中血管紧张素转化酶抑制肽的鉴定

获取原文
           

摘要

Angiotensin I-converting enzyme (ACE) inhibitory activity of razor clam hydrolysates produced using five proteases, namely, pepsin, trypsin, alcalase, flavourzyme and proteases from Actinomucor elegans T3 was investigated. Flavourzyme hydrolysate showed the highest level of degree of hydrolysis (DH) (45.87%) followed by A. elegans T3 proteases hydrolysate (37.84%) and alcalase (30.55%). The A. elegans T3 proteases was observed to be more effective in generating small peptides with ACE-inhibitory activity. The 3 kDa membrane permeate of A. elegans T3 proteases hydrolysate showed the highest ACE-inhibitory activity with an IC 50 of 0.79 mg/mL. After chromatographic separation by Sephadex G-15 gel filtration and reverse phase-high performance liquid chromatography, the potent fraction was subjected to MALDI/TOF-TOF MS/MS for identification. A novel ACE-inhibitory peptide (VQY) was identified exhibiting an IC 50 of 9.8 μM. The inhibitory kinetics investigation by Lineweaver-Burk plots demonstrated that the peptide acts as a competitive ACE inhibitor. The razor clam hydrolysate obtained by A. elegans T3 proteases could serve as a source of functional peptides with ACE-inhibitory activity for physiological benefits.
机译:研究了使用五种蛋白酶(胃蛋白酶,胰蛋白酶,碱性蛋白酶,风味酶和Actinomucor elegans T3的蛋白酶)生产的剃刀蛤水解产物的血管紧张素I转换酶(ACE)抑制活性。风味酶水解物显示最高的水解度(DH)(45.87%),其次是秀丽隐杆线虫T3蛋白酶水解物(37.84%)和碱性蛋白酶(30.55%)。观察到秀丽隐杆线虫T3蛋白酶在产生具有ACE抑制活性的小肽方面更有效。秀丽隐杆线虫T3蛋白酶水解物的3kDa膜渗透物显示出最高的ACE抑制活性,IC 50为0.79mg / mL。通过Sephadex G-15凝胶过滤和反相高效液相色谱进行色谱分离后,将有效馏分进行MALDI / TOF-TOF MS / MS鉴定。鉴定出一种新颖的ACE抑制肽(VQY),其IC 50为9.8μM。通过Lineweaver-Burk图进行的抑制动力学研究表明,该肽可作为竞争性ACE抑制剂。由秀丽隐杆线虫T3蛋白酶获得的剃刀蛤水解物可以用作具有ACE抑制活性的功能性肽的来源,从而具有生理益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号